Congress Asset Management »

Kymera Therapeutics shares owned by Congress Asset Management

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Congress Asset Management from 13F filings

Historical chart of Congress Asset Management investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Congress Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Congress Asset Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.8M 46k 40.20
2023-12-31 $1.2M 45k 25.46
2023-09-30 $628k 45k 13.90
2023-06-30 $1.0M 45k 22.99
2023-03-31 $1.3M 45k 29.63